Steg G, James DK, Atar D, Badano L, Lundqvist C, Borger M, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J. 2012;33:2569–619.
O’Gara PT, Kushner FG, Aschein DD, Casey D Jr, Chung M, de Lemos J, et al. ACCF/AHA guideline for the management of ST-segment elevation myocardial infarction: executive summary: a report of The American College of Cardiology Foundation/American Heart Association Task Force on Practice Guideline. J Am Coll Cardiol. 2013;61:485–510.
Jacobs AK, Antman EM, Faxon DP, Gregory T, Solis P. Development of systems of care for ST-elevation myocardial infarction patients: executive summary. Circulation. 2007;116:217–30.
Bosch X, Curós A, Argimon JM, Faixedas M, Figueras J, Jiménez JX, et al. Model of primary percutaneous intervention in Catalonia. Rev Esp Cardiol. 2011;11:51–60.
Huber K, Gersh BJ, Goldstein P, Granger CB, Armstrong PW. The organization, function, and outcomes of ST-elevation myocardial infarction networks worldwide: current state, unmet needs and future directions. Eur Heart J. 2014;35:1526–32.
Rodriguez-Leor O, Fernandez-Nofrerias E, Mauri J, Carrillo X, Salvatella N, Curós A, et al. Integration of a local into a regional primary angioplasty action plan (the Catalan Codi Infart network) reduces time to reperfusion. Int J Cardiol. 2013;168:4354–7.
Fosbol EL, Granger CB, Jollis JG, Monk L, Lin L, Lytle BL, et al. The impact of a statewide pre-hospital STEMI strategy to bypass hospitals without percutaneous coronary intervention capability on treatment times. Circulation. 2013;127:604–12.
Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Engl J Med. 2007;356:2388–98.
García-García C, Sanz G, Valle V, Molina L, Sala J, Subirana I, et al. Trends in in-hospital mortality and 6-months outcomes in patients with a first acute myocardial infarction. Change over the last decade. Rev Esp Cardiol. 2010;63:1136–44.
Flores-Mateo G, Grau M, O'Flaherty M, Ramos R, Elosua R, Violan-Fors C, et al. Analyzing the coronary heart disease mortality decline in a Mediterranean population: Spain 1988–2005. Rev Esp Cardiol. 2011;64:988–96.
García-García C, Subirana I, Sala J, Bruguera J, Sanz G, Valle V, et al. Long-term prognosis of first myocardial infarction according to the electrocardiographic pattern (ST elevation myocardial infarction, non-ST elevation myocardial infarction and non-classified myocardial infarction) and revascularization procedures. Am J Cardiol. 2011;108:1061–7.
Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503–16.
Boden WE, O'Rourke RA, Teo KK, Maron DJ, Hartigan PM, Sedlis SP, et al. Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial). Am J Cardiol. 2009;104:1–4.
Epstein SE, Waksman R, Pichard AD, Kent KM, Panza JA. Percutaneous coronary intervention versus medical therapy in stable coronary artery disease: the unresolved conundrum. JACC Cardiovasc Interv. 2013;6:993–8.
Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002. Summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation. 2002;106:1893–900.
Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J. 2008;29:2909–45.
Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Phisicians: 2007 Writing Group to review new evidence and update the ACC/AHA 2004 Guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 Writing Committee. Circulation. 2008;117:296–329. Erratum in: Circulation. 2008;117:e162.
Barrabés JA, Bardají A, Jiménez-Candil J, del Nogal SF, Bodí V, Basterra N, et al. Prognosis and management of acute coronary syndrome in Spain in 2012: the DIOCLES study. Rev Esp Cardiol. 2015;68:98–106.
Widimsky P, Zelizko M, Jansky P, Tousek F, Holm F, Aschermann M, et al. The incidence, treatment strategies and outcomes of acute coronary syndromes in the "reperfusion network" of different hospital types in the Czech Republic: results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry. Int J Cardiol. 2007;119:212–9.
Polańska-Skrzypczyk M, Karcz M, Bekta P, Kępka C, Sielatycki P, Rużyłło W, et al. Total ischaemic time and 9-year outcomes in STEMI patients treated with pPCI. Int J Cardiol. 2015;184:184–9.
Widimsky P, Wijns W, Fajadet J, de Belder M, Knot J, Aaberge L, et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J. 2010;31:943–57.
Menees D, Peterson E, Wanhg Y, Curtis JP, Messenger JC, Rumsfeld JS, et al. Door-to-Balloon time and mortality among patients undergoing primary PCI. N Engl J Med. 2013;369:901–9.
Kristensen S, Laut K, Fajadet J, Kaifoszova Z, Kala P, Di Mario C, et al. Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries. Eur Heart J. 2014;35:1957–70.
Pedersen F, Butrymovich V, Kelbæk H, Wachtell K, Helqvist S, Kastrup J, et al. Short- and long-term cause of death in patients treated with primary PCI for STEMI. J Am Coll Cardiol. 2014;64:2101–8.
Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045–57.
Yang JH, Hahn JY, Song YB, Choi SH, Choi JH, Lee SH, et al. Association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. J Am Coll Cardiol. 2014;7:592–601.
Nakatani D, Sakata Y, Suna S. Impact of beta blockade therapy on long-term mortality after ST-segment elevation acute myocardial infarction in the percutaneous coronary intervention era. Am J Cardiol. 2013;111:457–64.